Monocyte enriched apheresis for preparation of dendritic cells (DC) to be used in cellular therapy

Transfusion and Apheresis Science

Volumn 33, Issue 2, 2005, Pages 165-173

  Svensson, Anna ^a   Adamson, Lars ^a   Pisa, Pavel ^a   Petersson, Max ^a   Hansson, Mona ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Efficacy; Healthy volunteers; Leukapheresis; On line sample; Patients

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; APHERESIS; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE TARGETING; HUMAN; LEUKAPHERESIS; MALE; MATHEMATICAL COMPUTING; MONOCYTE; ONLINE SYSTEM;

ADULT; AGED; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; NEOPLASMS;

EID: 24944435781     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2005.04.009     Document Type: Article

References (23)

1. I.M. Svane, M.L. Soot, S. Buus, and H.E. Johnsen Clinical application of dendritic cells in cancer vaccination therapy APMIS 111 7-8 2003 818 834 [Review]
2. D.H. Chang, and M.V. Dhodapkar Dendritic cells and immunotherapy for cancer Int J Hematol 77 5 2003 439 443 [Review]
3. G. Schuler, B. Schuler-Thurner, and R.M. Steinman The use of dendritic cells in cancer immunotherapy Curr Opin Immunol 15 2 2003 138 147 [Review]
4. X.D. Nguyen, H. Eichler, A. Sucker, U. Hofmann, D. Schadendorf, and H. Kluter Collection of autologous monocytes for dendritic cell vaccination therapy in metastatic melanoma patients Transfusion 42 4 2002 428 432
5. A. Tazbirkova, M. Okai, D.C. Horley, T.M. Crough, A. Maksoud, and M. Nieda Effects of leukapheresis protocol, cell processing and cryopreservation on the generation of monocyte-derived DC for immune therapy Cytotherapy 5 1 2003 31 39
6. E.F. Strasser, T.G. Berger, V. Weisbach, R. Zimmermann, J. Ringwald, and B. Schuler-Thurner Comparison of two apheresis systems for the collection of CD14+ cells intended to be used in dendritic cell culture Transfusion 43 9 2003 1309 1316
7. A.K. Palucka, M.V. Dhodapkar, S. Paczesny, S. Burkeholder, K.M. Wittkowski, and R.M. Steinman Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma J Immunother 26 5 2003 432 439
8. L. Garderet, H. Cao, J. Salamero, V. Verge, E. Tisserand, and S. Scholl In vitro production of dendritic cells from human blood monocytes for therapeutic use Hematother Stem Cell Res 10 4 2001 553 567
9. G.M. Zou, and Y.K. Tam Cytokines in the generation and maturation of dendritic cells: recent advances Eur Cytokine Network 13 2 2002 186 199 [Review]
10. J. Babatz, C. Rollig, U. Oelschlagel, S. Zhao, G. Ehninger, and M. Schmitz Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study J Hematother Stem Cell Res 12 5 2003 515 523
11. F. Meyer-Wentrup, and S. Burdach Efficacy of dendritic cell generation for clinical use: recovery and purity of monocytes and mature dendritic cells after immunomagnetic sorting or adherence selection of CD14+ starting populations J Hematother Stem Cell Res 12 3 2003 289 299
12. T. Felzmann, V. Witt, D. Wimmer, G. Ressmann, D. Wagner, and P. Paul Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection Cytotherapy 5 5 2003 391 398
13. E.C. Wong Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy Cytotherapy 3 1 2001 19 29
14. L. Adamson, A. Palmborg, A. Svensson, A. Lundqvist, M. Hansson, and R. Kiessling Development of a technology platform for large-scale clinical grade production of dendritic cells Cytotherapy 6 4 2004 363 371
15. A. Svensson, P. Engervall, T. Söderström, and M. Hansson PBSC harvests individually optimized by pre-collection CD34+ values and on-line flowcytometry analysis of the mononuclear cell enrichment Cytotherapy 1 1999 165 174
16. P. Hersey, S.W. Menzies, G.M. Halliday, T. Nguyen, M.L. Farrelly, and C. DeSilva Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma Cancer Immunol Immunother 53 2 2004 125 134
17. G. Cull, L. Durrant, C. Stainer, A. Haynes, and N. Russell Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma Br J Haematol 107 3 1999 648 655
18. P. Thumann, I. Moc, J. Humrich, T.G. Berger, E.S. Schultz, and G. Schuler Antigen loading of dendritic cells with whole tumor cell preparations J Immunol Methods 277 1-2 2003 1 16
19. J. Bubenik Genetically engineered dendritic cell-based cancer vaccines Int J Oncol 18 3 2001 475 478
20. T. Hayashi, H. Tanaka, J. Tanaka, R. Wang, B.J. Averbook, and P.A. Cohen Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion Clin Immunol 104 1 2002 14 20
21. T.A. Lane, A. Bashey, E. Carrier, P. Holman, J. Castro, and M. Mullen Improving the efficiency of PBSC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells Cytotherapy 6 4 2004 318 327
22. L.M. Knudsen, K. Nikolaisen, E. Gaarsdal, and H.E. Johnsen Kinetic studies during peripheral blood stem cell collection show CD34+ cell recruitment intra-apheresis J Clin Apheresis 16 3 2001 114 119
23. A.K. Moller, E. Dickmeiss, C.H. Geisler, and L.D. Christensen Recruitment of CD34+ cells during large-volume leukapheresis J Hematother Stem Cell Res 10 6 2001 837 853